Peer Review History
| Original SubmissionJune 11, 2024 |
|---|
|
Dear Prof. Silber, Thank you very much for submitting your manuscript "Branched chain amino acids modulate the proteomic profile of Pro-induced differentiation for the infective stages of Trypanosoma cruzi" for consideration at PLOS Neglected Tropical Diseases. As with all papers reviewed by the journal, your manuscript was reviewed by members of the editorial board and by several independent reviewers. The reviewers appreciated the attention to an important topic. Based on the reviews, we are likely to accept this manuscript for publication, providing that you modify the manuscript according to the review recommendations. Please prepare and submit your revised manuscript within 30 days. If you anticipate any delay, please let us know the expected resubmission date by replying to this email. When you are ready to resubmit, please upload the following: [1] A letter containing a detailed list of your responses to all review comments, and a description of the changes you have made in the manuscript. Please note while forming your response, if your article is accepted, you may have the opportunity to make the peer review history publicly available. The record will include editor decision letters (with reviews) and your responses to reviewer comments. If eligible, we will contact you to opt in or out [2] Two versions of the revised manuscript: one with either highlights or tracked changes denoting where the text has been changed; the other a clean version (uploaded as the manuscript file). Important additional instructions are given below your reviewer comments. Thank you again for your submission to our journal. We hope that our editorial process has been constructive so far, and we welcome your feedback at any time. Please don't hesitate to contact us if you have any questions or comments. Sincerely, Álvaro Acosta-Serrano Section Editor PLOS Neglected Tropical Diseases *********************** Reviewer's Responses to Questions Key Review Criteria Required for Acceptance? As you describe the new analyses required for acceptance, please consider the following: Methods -Are the objectives of the study clearly articulated with a clear testable hypothesis stated? -Is the study design appropriate to address the stated objectives? -Is the population clearly described and appropriate for the hypothesis being tested? -Is the sample size sufficient to ensure adequate power to address the hypothesis being tested? -Were correct statistical analysis used to support conclusions? -Are there concerns about ethical or regulatory requirements being met? Reviewer #1: Methods all fine. Reviewer #2: The experimental workflow is adequate, the data analysis robust and comparisons revealed a proteome remodelling snapshot where valine emerged as the most influential treatment. Overall protein coverage was 7.6% (1,457 out of 19,242 proteins for CL-Brener proteome). Changes in protein abundances depict a phenotype mainly driven by metabolic responses, attenuated translation and proteolytic rates, and changes in flagellar and parasite cell surface components. While the study didn't pinpoint exactly which proteins control the parasites' transformation, it still provides valuable insights. On a technical note, trypanosomes proteome is poorly annotated, and this type of studies may improve the limited annotation present in nearly 33% of hypothetical proteins. -------------------- Results -Does the analysis presented match the analysis plan? -Are the results clearly and completely presented? -Are the figures (Tables, Images) of sufficient quality for clarity? Reviewer #1: In part. As detailed in my comments ot authors, the basic analysis of fine, it it the higher level interoretation that is problematic. Reviewer #2: (No Response) -------------------- Conclusions -Are the conclusions supported by the data presented? -Are the limitations of analysis clearly described? -Do the authors discuss how these data can be helpful to advance our understanding of the topic under study? -Is public health relevance addressed? Reviewer #1: The conclusions are not fully realised or connected with the data. Reviewer #2: (No Response) -------------------- Editorial and Data Presentation Modifications? Use this section for editorial suggestions as well as relatively minor modifications of existing data that would enhance clarity. If the only modifications needed are minor and/or editorial, you may wish to recommend “Minor Revision” or “Accept”. Reviewer #1: (No Response) Reviewer #2: The data presented warrants publication in PNTD and I have made a few suggestions that can aid readers to better grasp the most relevant outputs of this study. Major points: - The proteomic data provide evidence of a potential role for TAT as a frontline sensing component when free amino acids are the main carbon and nitrogen sources found in the culture media. It will be informative to presenting an average LFQ comparison across the media conditions assayed for TAT and other metabolic components such as PK which stood out as proteins whose abundance was remarkably changed. Bars plot would be enough. - The FAZ4, Gb4 and autophagy-related protein 24 are additional candidates that can be featured from this study in both abstract and the discussion sections. Is there any common feature in domain architecture or subcellular localisation among these? These protein hits might be worth studying further. - It is fascinating to see that a single isomeric modification (i.e., leucine x isoleucine) can be decoded by the parasite and finely influence proteome changes. Another highlight. Minor points: - The use of the acronym ‘pro’ is excessive and might add some confusion as this can also be interpreted as synonym of enhancer/promoter/inducer. I suggest naming it on its full extension throughout the main sections (tittle, abstract, conclusions). For example, sentence in line 106: ‘Given that i) Pro is a pro-metacyclogenic amino acid’ can be misleading. - Using the term ‘protein expression’ is not adequate for the context of this type of study. Although it’s been widely used the word expression should only refer to gene expression. In the context of gene-encoded proteins I would suggest replacing expression for protein synthesis, protein levels or protein abundance. Protein expression is conceptually flawed. - Line 340: How do the authors infer metabolic changes from proteome data? The variations observed in enzymes of glutamate, proline, serine, threonine and glutamine metabolism reflect an overall metabolic remodelling that, in my view, is mostly driven by the metabolic condition imparted in the cultivation media. - Comparisons between protein changes observed in TAU-proline x TAU-proline+valine (Lines 360-70) are not properly presented as the changes highlighted do not specify in what condition the up/down regulated hits are enriched. For example, in which comparison were the 78 downregulated hits seen? Similarly written in line 376. Please note that data presented in lines 389-409 are much easier to follow on and correlate with the supporting figures. - Line 459-60 (Discussion section) where the authors state the difference in substrate preferences might reflect specific nutritional needs throughout life cycle. I think it would be useful to elaborate more around this claim and, if possible, provide a documented example. - Do the authors think that an increased amino acid catabolic activity can be a trigger of metacyclogenesis arrest? This is put in the context of increased GS activity in the TAU-proline plus valine dependent metacyclogenesis. -------------------- Summary and General Comments Use this section to provide overall comments, discuss strengths/weaknesses of the study, novelty, significance, general execution and scholarship. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. If requesting major revision, please articulate the new experiments that are needed. Reviewer #1: This is an interesting paper that seeks to address the question of the impact of different amino acids on differentiation in T. cruzi. Given that differentiation is frequently associated with stress conditions, uderstanding the metabolic consequences required for and arising from differentiation is important to understand the basic biology behind the process. Technically I have no real criticisms or comments as the proteomics approach is absolutely standard and clearly carried out correctly. There is some noise revealed in the PCA analysis in F1 revealing an outlier for several of the conditions, but that is unlikely to strongly impact the data. My real issue is to do with the manner in which the data are considered. As we work through the results there is little interpretation, but when we come to the discussion I was struck that the vast majorty of this coulle have been written without the proteomics having been done. There is little referemce back to this except for the section on the flagellar changes. I also worry that considerable issues arise from the use of GO terms which are poor for kinetoplastids and a lack of detailed analysis of more prominant changes. This seems to be a missed opportunity and I would suggest improving the discussion; the authors are well respected in this area and their insights would be valuable. Some specific things are below; Suggest Pro-induced is a bit cryptic in the title. Grammer odd for first sentence of abstract. down-regulated proteins are involved in biological processes such as the generation of energy, posttranscriptional regulation of gene expression and oxidation-reduction processes; on the other hand, up-regulated proteins participate in respiration and translation processes Not sure I quite grasp the distinction here - respiration is an energy genearator and posttranscriptional events include translation. Define TAT in discussion. The differences in the metabolic fates of the BCAAs might explain the phenotypic particularities observed in the metacyclic trypomastigotes differentiated in the presence of these amino acids. Yes, but how? In our case, some specific putative trans-sialidases proteins are downregulated in trypomastigotes obtained in TAU Pro-Leu and TAU Pro-Val when compared to metacyclics obtained in TAU Pro How does the present dataset compare to the other studies cited? Odd that if autophagy is activated that only see ATG24 and none of the catabolic or trafficking enzymes are noted. Reviewer #2: Professor Silber’s research group has greatly increased our understanding of how amino acids influence the trypanosomatids’ life cycle. Multiple lines of evidence have demonstrated that its functionality goes beyond its proteogenic role playing a pivotal role in parasite proliferation/infectivity, energy production, osmoregulation, and stress response. Particularly, proline acts as modulator of parasite differentiation and mitochondrial homeostasis. In this study the authors applied bottom-up proteomic profiling to delve into the function of branched chain amino acids (leucine, isoleucine and valine) during the differentiation process known as metacyclogenesis (i.e., cellular transformation from epimastigote to metacyclic trypomastigote). For this characterisation authors applied a well-established system of axenic cultivation in nutrient-scarce media, followed by affinity-based cell purification, which enabled the assessment of proteome-wide changes upon proline-dependent metacyclogenesis. -------------------- PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No Reviewer #2: No Figure Files: While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email us at figures@plos.org. Data Requirements: Please note that, as a condition of publication, PLOS' data policy requires that you make available all data used to draw the conclusions outlined in your manuscript. Data must be deposited in an appropriate repository, included within the body of the manuscript, or uploaded as supporting information. This includes all numerical values that were used to generate graphs, histograms etc.. For an example see here: http://www.plosbiology.org/article/info%3Adoi%2F10.1371%2Fjournal.pbio.1001908#s5. Reproducibility: To enhance the reproducibility of your results, we recommend that you deposit your laboratory protocols in protocols.io, where a protocol can be assigned its own identifier (DOI) such that it can be cited independently in the future. Additionally, PLOS ONE offers an option to publish peer-reviewed clinical study protocols. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols References Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article's retracted status in the References list and also include a citation and full reference for the retraction notice. |
| Revision 1 |
|
Dear Prof. Silber, We are pleased to inform you that your manuscript 'Branched-chain amino acids modulate the proteomic profile of Trypanosoma cruzi metacyclogenesis induced by proline' has been provisionally accepted for publication in PLOS Neglected Tropical Diseases. Before your manuscript can be formally accepted you will need to complete some formatting changes, which you will receive in a follow up email. A member of our team will be in touch with a set of requests. Please note that your manuscript will not be scheduled for publication until you have made the required changes, so a swift response is appreciated. IMPORTANT: The editorial review process is now complete. PLOS will only permit corrections to spelling, formatting or significant scientific errors from this point onwards. Requests for major changes, or any which affect the scientific understanding of your work, will cause delays to the publication date of your manuscript. Should you, your institution's press office or the journal office choose to press release your paper, you will automatically be opted out of early publication. We ask that you notify us now if you or your institution is planning to press release the article. All press must be co-ordinated with PLOS. Thank you again for supporting Open Access publishing; we are looking forward to publishing your work in PLOS Neglected Tropical Diseases. Best regards, Álvaro Acosta-Serrano Section Editor PLOS Neglected Tropical Diseases *********************************************************** |
| Formally Accepted |
|
Dear Prof. Silber, We are delighted to inform you that your manuscript, "Branched-chain amino acids modulate the proteomic profile of Trypanosoma cruzi metacyclogenesis induced by proline," has been formally accepted for publication in PLOS Neglected Tropical Diseases. We have now passed your article onto the PLOS Production Department who will complete the rest of the publication process. All authors will receive a confirmation email upon publication. The corresponding author will soon be receiving a typeset proof for review, to ensure errors have not been introduced during production. Please review the PDF proof of your manuscript carefully, as this is the last chance to correct any scientific or type-setting errors. Please note that major changes, or those which affect the scientific understanding of the work, will likely cause delays to the publication date of your manuscript. Note: Proofs for Front Matter articles (Editorial, Viewpoint, Symposium, Review, etc...) are generated on a different schedule and may not be made available as quickly. Soon after your final files are uploaded, the early version of your manuscript will be published online unless you opted out of this process. The date of the early version will be your article's publication date. The final article will be published to the same URL, and all versions of the paper will be accessible to readers. Thank you again for supporting open-access publishing; we are looking forward to publishing your work in PLOS Neglected Tropical Diseases. Best regards, Shaden Kamhawi co-Editor-in-Chief PLOS Neglected Tropical Diseases Paul Brindley co-Editor-in-Chief PLOS Neglected Tropical Diseases |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .